Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Xenon Pharmaceuticals Inc.(XENE) | 994,227 | 1,144,021 | +149,794 | $38.76M | $45.04M | 6.99% | +$6.28M |
| Apogee Therapeutics Inc | 836,283 | 664,198 | -172,085 | $32.91M | $39.01M | 6.05% | +$6.11M |
| Nuvalent Inc | 200,000 | 337,500 | +137,500 | $15.17M | $34.53M | 5.36% | +$19.35M |
| Arcellx Inc COMMON STOCK | 460,000 | 400,000 | -60,000 | $25.39M | $33.40M | 5.18% | +$8.02M |
| Alkermes plcSHS(ALKS) | 650,000 | 1,000,000 | +350,000 | $15.66M | $27.99M | 4.34% | +$12.32M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 1,450,000 | 1,400,000 | -50,000 | $23.56M | $25.23M | 3.91% | +$1.67M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 110,000 | 100,000 | -10,000 | $30.82M | $21.22M | 3.29% | -$9.60M |
| Crinetics Pharmaceuticals In | 515,000 | 400,000 | -115,000 | $23.07M | $20.44M | 3.17% | -$2.63M |
| Nurix Therapeutics, Inc.(NRIX) | 912,000 | 860,399 | -51,601 | $19.03M | $19.33M | 3.00% | +$299.7K |
| Vera Therapeutics, Inc.CL A(VERA) | 375,000 | 435,000 | +60,000 | $13.57M | $19.23M | 2.98% | +$5.66M |
| Verona Pharma PlcADS | 700,000 | 650,000 | -50,000 | $10.12M | $18.70M | 2.90% | +$8.58M |
| Autolus Therapeutics plcADS(AUTL) | 4,300,000 | 4,500,000 | +200,000 | $14.96M | $16.34M | 2.53% | +$1.37M |
| Centessa Pharmaceuticals PlcADS | 1,135,702 | 965,612 | -170,090 | $10.26M | $15.44M | 2.40% | +$5.18M |
| Inozyme Pharma Inc | 2,856,252 | 2,822,318 | -33,934 | $12.74M | $14.76M | 2.29% | +$2.02M |
| Spyre Therapeutics, Inc.(SYRE) | 513,420 | 498,420 | -15,000 | $12.07M | $14.66M | 2.27% | +$2.59M |
| Omeros CorpNOTE 5 250 2 1 | 0 | 0 | 0 | $8.08M | $14.64M | 2.27% | +$6.55M |
| Kura Oncology, Inc.(KURA) | 650,000 | 687,785 | +37,785 | $13.38M | $13.44M | 2.09% | +$55.8K |
| Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS) | 0 | 0 | 0 | $8.64M | $13.05M | 2.02% | +$4.41M |
| Establishment Labs Holdings Inc.(ESTA) | 223,407 | 290,447 | +67,040 | $10.15M | $12.57M | 1.95% | +$2.42M |
| Viridian Therapeutics, Inc.(VRDN) | 150,000 | 525,000 | +375,000 | $1.95M | $11.94M | 1.85% | +$9.99M |
| Wave Life Sciences, Inc.SHS(WVE) | 375,000 | 1,400,000 | +1,025,000 | $1.87M | $11.48M | 1.78% | +$9.61M |
| Karyopharm Therapeutics IncNOTE 3 000 10 1 | 0 | 0 | 0 | $6.30M | $9.62M | 1.49% | +$3.32M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 349,836 | +349,836 | $0 | $8.57M | 1.33% | +$8.57M |
| Rezolute, Inc.(RZLT) | 1,850,000 | 1,700,000 | -150,000 | $7.96M | $8.24M | 1.28% | +$290.0K |
| Merus N V | 125,000 | 161,741 | +36,741 | $7.40M | $8.08M | 1.25% | +$684.3K |
| Astria Therapeutics Inc | 975,606 | 725,106 | -250,500 | $8.88M | $7.98M | 1.24% | -$894.6K |
| BeOne Medicines AGADR(ONC) | 110,000 | 35,000 | -75,000 | $15.69M | $7.86M | 1.22% | -$7.84M |
| Newamsterdam Pharma Company ORDINARY SHARES | 423,155 | 472,390 | +49,235 | $8.13M | $7.84M | 1.22% | -$287.1K |
| BridgeBio Pharma, Inc.(BBIO) | 100,000 | 300,000 | +200,000 | $2.53M | $7.64M | 1.19% | +$5.11M |
| Climb Bio, Inc.(CLYM) | 1,670,661 | 1,500,000 | -170,661 | $11.88M | $7.63M | 1.18% | -$4.24M |
| Axsome Therapeutics, Inc.(AXSM) | 80,000 | 80,000 | 0 | $6.44M | $7.19M | 1.12% | +$749.6K |
| Erasca, Inc.(ERAS) | 2,499,431 | 2,499,431 | 0 | $5.90M | $6.82M | 1.06% | +$924.8K |
| Geron Corporation(GERN) | 1,500,000 | 1,500,000 | 0 | $6.36M | $6.81M | 1.06% | +$450.0K |
| Perspective Therapeutics, Inc.(CATX) | 550,000 | 500,000 | -50,000 | $5.48M | $6.67M | 1.04% | +$1.19M |
| Immunovant, Inc.(IMVT) | 346,088 | 225,000 | -121,088 | $9.14M | $6.41M | 1.00% | -$2.72M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 50,000 | 325,000 | +275,000 | $1.30M | $6.30M | 0.98% | +$5.00M |
| Vaxcyte, Inc.(PCVX) | 60,000 | 50,000 | -10,000 | $4.53M | $5.71M | 0.89% | +$1.18M |
| Arvinas, Inc.(ARVN) | 0 | 225,000 | +225,000 | $0 | $5.54M | 0.86% | +$5.54M |
| Terns Pharmaceuticals Inc | 0 | 600,000 | +600,000 | $0 | $5.00M | 0.78% | +$5.00M |
| Springworks Therapeutics Inc | 69,999 | 147,500 | +77,501 | $2.64M | $4.73M | 0.73% | +$2.09M |
| Cullinan Therapeutics, Inc.(CGEM) | 263,817 | 263,817 | 0 | $4.60M | $4.42M | 0.69% | -$184.7K |
| Travere Therapeutics, Inc.NOTE 2 250 3 0(TVTX) | 0 | 0 | 0 | $0 | $4.32M | 0.67% | +$4.32M |
| Celldex Therapeutics, Inc.(CLDX) | 475,400 | 125,000 | -350,400 | $17.59M | $4.25M | 0.66% | -$13.35M |
| Mineralys Therapeutics, Inc.(MLYS) | 327,959 | 350,000 | +22,041 | $3.84M | $4.24M | 0.66% | +$401.4K |
| Insmed Incorporated(INSM) | 125,000 | 50,000 | -75,000 | $8.38M | $3.65M | 0.57% | -$4.72M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 350,000 | 350,000 | 0 | $3.52M | $3.51M | 0.54% | -$10.5K |
| Nextcure Inc | 1,687,955 | 2,302,598 | +614,643 | $2.68M | $3.15M | 0.49% | +$470.7K |
| Savara Inc.(SVRA) | 1,546,850 | 700,000 | -846,850 | $6.23M | $2.97M | 0.46% | -$3.27M |
| Nkarta, Inc.(NKTX) | 200,000 | 650,000 | +450,000 | $1.18M | $2.94M | 0.46% | +$1.76M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 155,000 | 75,000 | -80,000 | $5.30M | $2.92M | 0.45% | -$2.37M |
| Immatics N.V.SHS(IMTX) | 300,000 | 250,000 | -50,000 | $3.49M | $2.85M | 0.44% | -$633.5K |
| Helix Acquisition Corp IiCL A | 250,000 | 250,000 | 0 | $2.56M | $2.61M | 0.41% | +$57.5K |
| Context Therapeutics Inc.(CNTX) | 1,619,140 | 1,321,153 | -297,987 | $3.25M | $2.59M | 0.40% | -$656.9K |
| Inari Med Inc | 200,000 | 60,000 | -140,000 | $9.63M | $2.47M | 0.38% | -$7.16M |
| Roivant Sciences Ltd.SHS(ROIV) | 351,587 | 201,587 | -150,000 | $3.72M | $2.33M | 0.36% | -$1.39M |
| Kezar Life Sciences Inc | 1,761,778 | 2,511,778 | +750,000 | $1.06M | $1.94M | 0.30% | +$885.0K |
| COMPASS Pathways plcADS(CMPS) | 500,512 | 300,512 | -200,000 | $3.02M | $1.89M | 0.29% | -$1.13M |
| Tectonic Therapeutic, Inc.(TECX) | 58,331 | 58,331 | 0 | $960.7K | $1.77M | 0.27% | +$806.7K |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 202,599 | 212,974 | +10,375 | $1.92M | $1.49M | 0.23% | -$425.8K |
| Soleno Therapeutics Inc | 0 | 25,000 | +25,000 | $0 | $1.26M | 0.20% | +$1.26M |
| Aerovate Therapeutics Inc | 200,000 | 600,000 | +400,000 | $332.0K | $1.25M | 0.19% | +$922.0K |
| Q32 Bio Inc.(QTTB) | 27,777 | 27,777 | 0 | $498.6K | $1.24M | 0.19% | +$740.8K |
| Verastem, Inc.(VSTM) | 0 | 400,000 | +400,000 | $0 | $1.20M | 0.19% | +$1.20M |
| BioMarin Pharmaceutical Inc.(BMRN) | 0 | 15,000 | +15,000 | $0 | $1.05M | 0.16% | +$1.05M |
| Zura Bio LimitedCL A(ZURA) | 223,335 | 223,335 | 0 | $781.7K | $906.7K | 0.14% | +$125.1K |
| Puma Biotechnology, Inc.(PBYI) | 250,000 | 250,000 | 0 | $815.0K | $637.5K | 0.10% | -$177.5K |
| Repare Therapeutics Inc | 0 | 173,351 | +173,351 | $0 | $596.3K | 0.09% | +$596.3K |
| Kyverna Therapeutics, Inc.(KYTX) | 200,000 | 119,900 | -80,100 | $1.50M | $586.3K | 0.09% | -$913.7K |
| Adagio Medical Holdings, Inc.(ADGM) | 0 | 213,235 | +213,235 | $0 | $550.1K | 0.09% | +$550.1K |
| Immatics N.VW EXP 07 01 202 | 187,204 | 187,204 | 0 | $484.9K | $430.6K | 0.07% | -$54.3K |
| Avalo Therapeutics, Inc.(AVTX) | 45,000 | 45,000 | 0 | $561.1K | $425.7K | 0.07% | -$135.4K |
| Voyager Therapeutics, Inc.(VYGR) | 0 | 51,727 | +51,727 | $0 | $302.6K | 0.05% | +$302.6K |
| Neurobo Pharmaceuticals In | 89,222 | 89,222 | 0 | $431.8K | $282.8K | 0.04% | -$149.0K |
| Genelux Corporation(GNLX) | 100,000 | 100,000 | 0 | $195.0K | $237.0K | 0.04% | +$42.0K |
| Whitehawk Therapeutics, Inc.(WHWK) | 0 | 47,019 | +47,019 | $0 | $96.9K | 0.02% | +$96.9K |
| Promis Neurosciences Inc | 265,958 | 30,643 | -235,315 | $398.9K | $38.3K | 0.01% | -$360.6K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 75,000 | 75,000 | 0 | $4.5K | $5.3K | 0.00% | +$727 |
| ADC Therapeutics SASHS(ADCT) | 474,744 | 0 | -474,744 | $1.50M | $0 | — | -$1.50M |
| Alnylam Pharmaceuticals, Inc.NOTE 1 000 9 1(ALNY) | 0 | 0 | 0 | $16.20M | $0 | — | -$16.20M |
| Arca Biopharma Inc | 72,484 | 0 | -72,484 | $277.6K | $0 | — | -$277.6K |
| Arya Sciences Acqu Corp IvCL A | 133,500 | 0 | -133,500 | $1.53M | $0 | — | -$1.53M |
| Black Diamond Therapeutics I | 650,000 | 0 | -650,000 | $3.03M | $0 | — | -$3.03M |
| BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO) | 0 | 0 | 0 | $17.26M | $0 | — | -$17.26M |
| Cerevel Therapeutics Hldng I | 500,000 | 0 | -500,000 | $20.45M | $0 | — | -$20.45M |
| Dyne Therapeutics, Inc.(DYN) | 100,000 | 0 | -100,000 | $3.53M | $0 | — | -$3.53M |
| Elevation Oncology Inc | 1,468,825 | 0 | -1,468,825 | $3.97M | $0 | — | -$3.97M |
| Hillevax Inc | 265,859 | 0 | -265,859 | $3.84M | $0 | — | -$3.84M |
| Iovance Biotherapeutics, Inc.(IOVA) | 100 | 0 | -100 | $802 | $0 | — | -$802 |
| Mersana Therapeutics Inc | 767,000 | 0 | -767,000 | $1.54M | $0 | — | -$1.54M |
| Morphic Hldg Inc | 250,573 | 0 | -250,573 | $8.54M | $0 | — | -$8.54M |
| Olema Pharmaceuticals, Inc.(OLMA) | 275,000 | 0 | -275,000 | $2.98M | $0 | — | -$2.98M |
| Passage Bio, Inc.(PASG) | 264,266 | 0 | -264,266 | $209.9K | $0 | — | -$209.9K |
| Rapt Therapeutics Inc | 75,000 | 0 | -75,000 | $228.8K | $0 | — | -$228.8K |
| Spdr Ser TrS P BIOTECH ST STR SP BIOT | 37,550 | 0 | -37,550 | $3.48M | $0 | — | -$3.48M |
| Tango Therapeutics, Inc.(TNGX) | 150,274 | 0 | -150,274 | $1.29M | $0 | — | -$1.29M |
| Vir Biotechnology, Inc.(VIR) | 200,000 | 0 | -200,000 | $1.78M | $0 | — | -$1.78M |
| Zymeworks Inc.(ZYME) | 191,127 | 0 | -191,127 | $1.63M | $0 | — | -$1.63M |